The Efficacy and Safety of Early MSAT on Radiating Pain in the Upper Extremity
The Effect of Early MSAT Treatment on Radiating Pain in the Upper Extremity Caused by Traffic Accidents: A Pragmatic Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
This study is a double blind, randomized controlled trail. condition/disease: radiating pain in the upper extremity. treatment/intervention: motion style acupuncture treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2023
CompletedFirst Posted
Study publicly available on registry
October 17, 2023
CompletedStudy Start
First participant enrolled
November 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedSeptember 4, 2025
September 1, 2025
9 months
October 12, 2023
September 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numeric Rating Scale(NRS) of radiating pain
NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their leg pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.
Screening, Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment
Secondary Outcomes (7)
Location of Radiating pain
Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment
VAS of Radiating pain
Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment
C-SPINE MRI
Taken within ±14 days of hospitalization
NRS of Neck pain
Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment
NDI
Baseline(day2), day5, Discharge 1 day, 1month after enrollment, 3month after enrollment
- +2 more secondary outcomes
Study Arms (2)
Cervical motion style acupuncture treatment(Trapezius, Rhomboid, Scalene)
EXPERIMENTALThe MSAT group recieved 3 sessions of MSAT; on second, third, fourth day after hospitalization. A trained doctor of Korean medicine with at least 3 years of clinical experience conducted the MSAT. The MSAT group were also treated with other Korean medical treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Korean medical treatment
ACTIVE COMPARATORThe control group were received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Interventions
Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation
acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine
Eligibility Criteria
You may qualify if:
- Patients aged 19-69 years on the date they sign the consent form.
- Patients who are suffered byradiating pain in the upper extremity that occurred within 3 days after traffic accident.
- Patients who are hospitalized due to traffic accident.
- Patients with NRS of radiating pain ≥ 5.
- Patients who provide consent to participate in the trial and return the informed consent form.
You may not qualify if:
- Patients with a specific serious disease that may cause radiating pain: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients with progressive neurological deficits or with severe neurological symptoms.
- Patients with medical history of cervical surgery or thoracic surgery within the last three weeks.
- Patients who have radiating pain in upper extremity before the traffic accident.
- Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study.
- If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease.
- Patients who are pregnant or planning to become pregnant.
- Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
- Patients who are difficult to complete the research participation agreement.
- Other patients whose participation in the trial is judged by a researcher to be problematic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, 135-896, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
In-Hyuk Ha, phD
Jaseng Medical Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2023
First Posted
October 17, 2023
Study Start
November 6, 2023
Primary Completion
July 30, 2024
Study Completion
December 30, 2024
Last Updated
September 4, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share